The Precision in Clinical Trials Oncology Summit in Boston brings together industry leaders, clinical researchers, and biotech professionals to explore innovation and operational strategies in oncology trials, including topics such as biomarkers, digital health, decentralized trials and AI-driven data. The program emphasizes networking opportunities and practical, actionable insights to help trial sponsors and stakeholders navigate the evolving landscape of cancer-clinical-trial development.

Date: November 17-18, 2025
Location: Boston, MA
Booth: # 9

JOIN US!

Join us at Booth #9 to explore how our integrated solutions are helping sponsors accelerate oncology drug development with precision and agility. Catalent’s experts will be on-site to share how our tailored clinical supply and development solutions are enabling smarter, faster, and more patient-centric oncology trials.

Let’s connect in Boston and shape the future of cancer research together.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.

 

 

More products. Better treatments. Reliably supplied.™